[HTML][HTML] CRISPR/nCas9-Based genome editing on GM2 gangliosidoses fibroblasts via non-viral vectors

AF Leal, J Cifuentes, V Quezada… - International Journal of …, 2022 - mdpi.com
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

[PDF][PDF] CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada… - Int. J. Mol …, 2022 - researchgate.net
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada, E Benincore-Flórez… - 2022 - agris.fao.org
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

[HTML][HTML] CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada… - … Journal of Molecular …, 2022 - ncbi.nlm.nih.gov
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.

AF Leal, J Cifuentes, V Quezada… - … Journal of Molecular …, 2022 - europepmc.org
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.

AF Leal, J Cifuentes, V Quezada… - International …, 2022 - search.ebscohost.com
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada… - International …, 2022 - search.proquest.com
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada, E Benincore-Flórez… - agris.fao.org
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …

[PDF][PDF] CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors

AF Leal, J Cifuentes, V Quezada… - Int. J. Mol …, 2022 - researchgate.net
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous
system due to the impaired GM2 ganglioside degradation inside the lysosome. Under …